Ergoteles LLC Olema Pharmaceuticals, Inc. Transaction History

Ergoteles LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$2.27 - $3.76 $88,316 - $146,286	38,906 New	38,906 $95,000
Q2 2022 Aug 12, 2022	BUY	$2.04 - $4.61 $227,868 - $514,937	111,700 Added 846.21%	124,900 $508,000
Q1 2022 May 13, 2022	SELL	$3.89 - $9.43 $80,912 - $196,144	-20,800 Reduced 61.18%	13,200 $56,000
Q4 2021 Feb 14, 2022	BUY	$8.75 - $30.71 $297,500 - $1.04 Million	34,000 New	34,000 $318,000

136

58.8M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $217M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.